HPTN 096

Phase:Open Label, Other
Principal Investigator(s):LaRon Nelson; Chris Beyrer; Robert Remien
Objective:The purpose of HPTN 096 is to assess an integrated, HIV status-neutral, population-based approach designed to reduce HIV incidence among Black MSM in the U.S. South by increasing HIV testing, pre-exposure prophylaxis (PrEP) use among Black MSM living without HIV, and viral suppression rates among Black MSM living with HIV.   More details are on the HPTN study website here.  Last updated June 10, 2022
Prevention Option(s):PrEP, Treatment U=U
Study Design:Open label, Randomized
Official Code: NCT05075967
Trial Sponsors: DIAID, HPTN, NAID
Start Date
End Date
April 1, 2022
June 30, 2027
Age range: 15 Years ↔ any
Population:Gay and Bisexual Men Who Have Sex with Men, People Living with HIV